These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Presumed corneal stromal graft rejection after deep anterior lamellar keratoplasty in a patient with systemic lupus erythematosis.
    Author: Jhanji V, Agarwal T, Sharma N, Vajpayee RB.
    Journal: Eye Contact Lens; 2010 Nov; 36(6):371-3. PubMed ID: 20935566.
    Abstract:
    PURPOSE: To report a case of presumed corneal stromal graft rejection after deep anterior lamellar keratoplasty in a patient with systemic lupus erythematosis (SLE). METHODS: Deep anterior lamellar keratoplasty was performed using the "bug bubble" technique in the left eye of a 14-year-old patient with keratoconus. Her medical records revealed a history of SLE that was in remission. Immediate postoperative course was uneventful. A best-corrected visual acuity (BCVA) of 20/40 was achieved at the end of 6 months. She was advised to taper off and stop topical corticosteroids by the end of 9 months. The patient presented with a red eye and reduced vision 11 months after surgery. At the time of presentation, the BCVA was 20/200, and ultrasonic central corneal thickness (CCT) was 792 μm in the operated eye. The anterior chamber was found to be quiet, and posterior segment examination was unremarkable. A diagnosis of presumed immune-mediated corneal stromal graft rejection was made. Treatment was started in the form of 1% prednisolone acetate eye drops every hour and 0.5% moxifloxacin hydrochloride eye drops thrice times daily. Hundred milligrams of methylprednisolone in 150 mL of 20% dextrose was administered intravenously. RESULTS: At the end of 2 weeks, the corneal edema cleared with a resultant CCT of 618 μm, and the BCVA improved to 20/40. CONCLUSIONS: Deep anterior lamellar keratoplasty does not eliminate the risk of corneal stromal rejection. Our patient had an associated history of SLE, which may necessitate a prolonged topical immunosuppression after corneal transplantation in these cases.
    [Abstract] [Full Text] [Related] [New Search]